(Q22252308)

English

Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function (English)

0 references

attention deficit hyperactivity disorder

0 references

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

Benedetto Vitiello

1

object named as

Benedetto Vitiello

author given names

Benedetto

author last names

Vitiello

1 reference

PubMed publication ID

7 February 2023

language of work or name

0 references

publication date

April 2008

0 references

Child and Adolescent Psychiatric Clinics of North America

0 references

17

0 references

2

0 references

459-74, xi

0 references

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

19 March 2017

Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

19 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

ADHD drugs and cardiovascular risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

19 March 2017

Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

19 March 2017

Stimulants and sudden death: what is a physician to do?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

27 September 2017

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

27 September 2017

Growth on stimulant medication; clarifying the confusion: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

27 September 2017

Cardiovascular effects of atomoxetine in children, adolescents, and adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

27 September 2017

Slowing of growth in height and weight on stimulants: a characteristic pattern

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

27 September 2017

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

27 September 2017

Abuse and toxicity of methylphenidate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

27 September 2017

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

27 September 2017

Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

27 September 2017

Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

27 September 2017

Sudden death from cardiac causes in children and young adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

27 September 2017

Growth of Hyperactive Children Treated With Methylphenidate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

27 September 2017

Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

30 May 2018

Long-term effects of extended-release mixed amphetamine salts treatment of attention- deficit/hyperactivity disorder on growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

30 May 2018

Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

30 May 2018

Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

30 May 2018

Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

30 May 2018

Methylphenidate and growth in hyperactive children. A controlled withdrawal study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

30 May 2018

Growth rebound after termination of stimulant drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

30 May 2018

Depression of Growth in Hyperactive Children on Stimulant Drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

30 May 2018

Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

19 June 2018

Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

The global market for ADHD medications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Effects of stimulants on Hispanic boys' height and weight

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Safety and tolerability of methylphenidate in preschool children with ADHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Stimulant-related reductions of growth rates in the PATS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Cardiovascular effects of mixed amphetamine salts extended release in the treatment of school-aged children with attention-deficit/hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Does Prolonged Therapy With a Long-Acting Stimulant Suppress Growth in Children With ADHD?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Stimulant treatment over 5 years: effects on growth.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

The effect of chronic methylphenidate administration on tooth maturation in a sample of Caucasian children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Atomoxetine ingestions in children: a report from poison centers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Growth and sexual maturation during long-term treatment with risperidone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Daily methylphenidate use slows the growth of children: a community based study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Methylphenidate-related growth impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Short-term cardiovascular effects of methylphenidate and adderall

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Predictors of adult height and weight in boys treated with methylphenidate for childhood behavior problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408826

29 November 2018

Combining methylphenidate and clonidine: a clinically sound medication option

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AHA Scientific Statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of long-term psychostimulant medication on growth of children with ADHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent trends in stimulant medication use among U.S. children

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Stimulant Medication on Growth Rates Across 3 Years in the MTA Follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sudden cardiac death: definitions and causes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolactin, growth hormone and growth responses in boys with attention deficit disorder and hyperactivity treated with methylphenidate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth of hyperactive children on maintenance regimen of methylphenidate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone, prolactin, and growth responses in hyperkinetic males treated with d-amphetamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone and prolactin secretion in adults and hyperactive children: Relation to methylphenidate serum levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.CHC.2007.11.010

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q22252308&oldid=1828428382"